Allogene Therapeutics, Inc. (ALLO) — Revenue
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $0 | -100.0% |
| 2024 | $22.0K | -76.8% |
| 2023 | $95.0K | -39.1% |
| 2022 | $156.0K | -99.9% |
| 2021 | $114.09M | — |
| 2020 | $0 | — |
| 2019 | $0 | — |
| Fiscal Year | Revenue | Change YoY |
|---|---|---|
| 2025 | $0 | -100.0% |
| 2024 | $22.0K | -76.8% |
| 2023 | $95.0K | -39.1% |
| 2022 | $156.0K | -99.9% |
| 2021 | $114.09M | — |
| 2020 | $0 | — |
| 2019 | $0 | — |